BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19798100)

  • 1. Cancer proteomics--an evolving battlefield. Conference on Cancer Proteomics 2009: Mechanistic Insights, Technological Advances & Molecular Medicine.
    Collins BC; Lau TY; O'Connor DP; Hondermarck H
    EMBO Rep; 2009 Nov; 10(11):1202-5. PubMed ID: 19798100
    [No Abstract]   [Full Text] [Related]  

  • 2. [Which molecular biology techniques must conform to the armamentarium for basic research in uro-oncology?].
    Oriola J
    Arch Esp Urol; 2013 Jun; 66(5):409-15. PubMed ID: 23793758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From bytes to bedside: data integration and computational biology for translational cancer research.
    Mathew JP; Taylor BS; Bader GD; Pyarajan S; Antoniotti M; Chinnaiyan AM; Sander C; Burakoff SJ; Mishra B
    PLoS Comput Biol; 2007 Feb; 3(2):e12. PubMed ID: 17319736
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular oncology in the post-genomic era: the challenge of proteomics.
    Mocellin S; Rossi CR; Traldi P; Nitti D; Lise M
    Trends Mol Med; 2004 Jan; 10(1):24-32. PubMed ID: 14720583
    [No Abstract]   [Full Text] [Related]  

  • 5. Proteomics for Early Diagnostics.
    Mali SB
    J Craniofac Surg; 2015 Jun; 26(4):1013-4. PubMed ID: 26080113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New oncology strategy: molecular targeting of cancer cells.
    Capriotti T
    Medsurg Nurs; 2004 Jun; 13(3):191-5. PubMed ID: 15219169
    [No Abstract]   [Full Text] [Related]  

  • 7. Translational oncology toward benefiting cancer patients: the Sun Yat-sen University Cancer Center experience.
    Guerin M; Qian C; Zhong Q; Cui Q; Guo Y; Bei J; Shao J; Zhu X; Huang W; Wu J; Liu R; Liu Q; Wang J; Jia W; Zheng X; Zeng Y
    Sci China Life Sci; 2016 Oct; 59(10):1057-1062. PubMed ID: 23132500
    [No Abstract]   [Full Text] [Related]  

  • 8. Can we deconstruct cancer, one patient at a time?
    Blau CA; Liakopoulou E
    Trends Genet; 2013 Jan; 29(1):6-10. PubMed ID: 23102584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular network analysis using reverse phase protein microarrays for patient tailored therapy.
    Speer R; Wulfkuhle J; Espina V; Aurajo R; Edmiston KH; Liotta LA; Petricoin EF
    Adv Exp Med Biol; 2008; 610():177-86. PubMed ID: 18593023
    [No Abstract]   [Full Text] [Related]  

  • 10. [Functional proteomics in oncology: to understand more than to describe].
    Com E; Hondermarck H
    Med Sci (Paris); 2007 Mar; 23 Spec No 1():27-30. PubMed ID: 17669350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
    Petricoin EF; Bichsel VE; Calvert VS; Espina V; Winters M; Young L; Belluco C; Trock BJ; Lippman M; Fishman DA; Sgroi DC; Munson PJ; Esserman LJ; Liotta LA
    J Clin Oncol; 2005 May; 23(15):3614-21. PubMed ID: 15908672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of new proteomics strategies for biology and medicine.
    Domon B; Broder S
    J Proteome Res; 2004; 3(2):253-60. PubMed ID: 15113101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCCN molecular testing white paper: effectiveness, efficiency, and reimbursement.
    Engstrom PF; Bloom MG; Demetri GD; Febbo PG; Goeckeler W; Ladanyi M; Loy B; Murphy K; Nerenberg M; Papagni P; Robson M; Sweetman RW; Tunis S; Demartino J; Larsen JK;
    J Natl Compr Canc Netw; 2011 Dec; 9 Suppl 6():S1-16. PubMed ID: 22203777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of molecular pathology in oncology: the clinician's perspective.
    Grade M; Becker H; Ghadimi BM
    Cell Oncol; 2004; 26(5-6):275-8. PubMed ID: 15623937
    [No Abstract]   [Full Text] [Related]  

  • 15. [Towards a better knowledge of breast cancer physiopathology: the proteomics approach].
    Hamrita B; Ben Nasr H; Hammann P; Kuhn L; Ben Anes A; Dimassi S; Chaieb A; Khairi H; Chahed K
    Ann Biol Clin (Paris); 2012 Oct; 70(5):553-65. PubMed ID: 23047902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 28th meeting of the Italian Cancer Society (SIC). New challenges of molecular oncology.
    Lollini PL; Pierotti MA; Passerini CG; Bani MR; Zupi G; Aglietta M; Albini A
    Tumori; 2002; 88(1):77-81. PubMed ID: 12004858
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in clinical oncoproteomics.
    Jain KK
    J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
    Burstein HJ; Krilov L; Aragon-Ching JB; Baxter NN; Chiorean EG; Chow WA; De Groot JF; Devine SM; DuBois SG; El-Deiry WS; Epstein AS; Heymach J; Jones JA; Mayer DK; Miksad RA; Pennell NA; Sabel MS; Schilsky RL; Schuchter LM; Tung N; Winkfield KM; Wirth LJ; Dizon DS
    J Clin Oncol; 2017 Apr; 35(12):1341-1367. PubMed ID: 28148207
    [No Abstract]   [Full Text] [Related]  

  • 19. [New techniques and methods in oncological biology: forward to molecular biopathology].
    Bidart JM; Assicot M
    Bull Cancer; 2001 Jan; 88(1):9-14. PubMed ID: 11182648
    [No Abstract]   [Full Text] [Related]  

  • 20. Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing.
    Rodriguez H; Pennington SR
    Cell; 2018 Apr; 173(3):535-539. PubMed ID: 29677503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.